Veeva Systems Inc (VEEV) KPIs and segments
Close on Nov 17, 2026Market cap $46.70BP/E 47.1Yield –
KPI & bộ phận
Chỉ số vận hành và bộ phận làm nên hoạt động của Veeva Systems · năm tài chính kết thúc ngày 31 tháng 1
Nhìn nhanh KPI của Veeva Systems: 51 chỉ số vận hành, trong đó có Normalized Billings, Calculated Billings và Deferred Revenue — Current (period end), lấy từ 209 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.
Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.
Năm tài chính của Veeva Systems kết thúc ngày 31 tháng 1 — Q2 FY2027 = CQ2 2026 (quý dương lịch).
Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.
| Thêm vào biểu đồ | Chỉ số | Q2 FY2027 | Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subscription($M) | 767 | 730 | 708 | 682 | 659 | 635 | 609 | 581 | 561 | 534 | 521 | 495 | |
R&D and Quality Solutions($M) | 419 | 392 | 352 | 329 | |||||||||
Professional services and other($M) | 161 | 153 | 128 | 129 | 130 | 124 | 112 | 118 | 115 | 116 | 109 | 122 | |
R&D Solutions($M) | 81.3 | 82.2 | 77.7 | 66.7 | 72.5 | 69.8 | 67.6 | 63.2 | 73.7 | ||||
Commercial Solutions($M) | 59.7 | 57.6 | 47.6 | 47.5 | 47.7 | 46.6 | 45.6 | 45.9 | 45.1 | 48.8 | 45.9 | 47.9 | |
North America($M) | 549 | 526 | 492 | 484 | 468 | 459 | 430 | 414 | 396 | 382 | 365 | 362 | |
Europe($M) | 284 | 266 | 252 | 238 | 233 | 217 | 204 | 199 | 198 | 190 | 183 | 172 | |
Asia Pacific($M) | 76.3 | 72.9 | 73.5 | 71.1 | 70.1 | 65.4 | 69.8 | 68.7 | 64.9 | 62.4 | 65.9 | 65.2 | |
Other international($M) | 18.6 | 18.2 | 18.2 | 17.1 | |||||||||
Middle East, Africa, and Latin America($M) | 18.3 | 18.2 | 17.1 | 17.6 | 17.4 | 17.0 | 16.4 | 16.9 | 16.5 | ||||
Subscription($M) | 661 | 631 | 611 | 588 | 565 | 556 | 525 | 498 | 482 | 456 | 444 | 420 | |
Professional services and other($M) | 34.9 | 31.0 | 11.3 | 23.4 | 28.5 | 28.8 | 14.8 | 26.6 | 23.3 | 20.7 | 12.6 | 28.3 | |
Normalized Billings($M)2 | 768 | 815 | 1,506 | 540 | 666 | 714 | 1,235 | 468 | 617 | 631 | 1,059 | 429 | |
Normalized billings growth y/y (stated)(%) | 19.0% | 15.0% | 18.0% | 13.0% | 10.0% | 16.0% | 17.0% | 12.0% | 11.0% | 11.0% | 14.0% | 15.0% | |
Customer term changes adjustment (Normalized − Calculated billings)($M) | 15 | -26 | -16 | 21 | 18 | 4 | -40 | -8 | 14 | 14 | 3 | 12 | |
Calculated Billings (Total Revenue + change in deferred revenue)($M)1 | 752 | 841 | 1,522 | 519 | 648 | 710 | 1,275 | 476 | 603 | 617 | 1,055 | 417 | |
Calculated billings growth y/y (stated)(%) | 16.0% | 18.0% | 19.0% | 9.0% | 7.0% | 15.0% | 21.0% | 14.0% | 9.0% | 8.0% | 14.0% | 12.0% | |
Deferred Revenue — Current (period end)($M)1 | 1,311 | 1,477 | 1,489 | 823 | 1,108 | 1,246 | 1,274 | 740 | 956 | 1,030 | 1,050 | 645 | |
Revenue recognized from beginning-of-year deferred revenue balance($M) | 640 | 606 | 581 | 556 | 518 | 492 | 466 | 440 | 425 | ||||
Unbilled Accounts Receivable — Total (period end)($M)2 | 69 | 59.8 | 50.6 | 57.5 | 50.3 | 48.4 | 40.8 | 45.5 | 39.4 | 38.8 | 36.4 | 44.8 | |
Unbilled receivables — Subscription revenue recognized not yet billed($M) | 24 | 15 | 11 | 13 | 8 | 8 | 8 | 6 | 4 | 4 | 4 | 7 | |
Unbilled receivables — Professional services contract assets not yet billable($M) | 45 | 45 | 40 | 45 | 42 | 40 | 33 | 39 | 35 | 35 | 32 | 38 | |
Subscription Remaining Performance Obligations — RPO (period end, legacy through Q3 FY2024)($M)1 | 813 | ||||||||||||
Current RPO share expected to be recognized within 12 months(%) | 95.0% | ||||||||||||
Capitalized Deferred Sales Commissions — Noncurrent (period end)($M)1 | 28 | 29 | 30 | 25 | 26 | 26 | 26 | 23 | 23 | 24 | 24 | 20 | |
Amortization of deferred sales commissions($M) | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | |
Allowance for Credit Losses on Accounts Receivable (period end)($M)1 | 0.10 | 0.07 | 0.26 | 0.17 | 0.60 | 0.56 | 0.06 | 0.16 | 0.25 | 0.22 | 0.52 | 0.55 | |
Provision for credit losses on accounts receivable (legacy through Q3 FY2025)($M) | 0.18 | 0.39 | -0.15 | 0.06 | 0.13 | ||||||||
Total Subscription Revenues($M)6 | 767 | 730 | 708 | 683 | 659 | 635 | 609 | 581 | 561 | 534 | 522 | 495 | |
Total subscription revenue growth y/y (stated)(%) | 16.0% | 15.0% | 16.0% | 17.0% | 17.0% | 19.0% | 17.0% | 17.0% | 19.0% | 29.0% | 13.0% | 12.0% | |
R&D and Quality Solutions — Subscription Revenue($M)1 | 419 | 392 | 381 | 365 | 352 | 329 | 315 | 302 | 289 | 273 | 260 | 244 | |
R&D and Quality subscription revenue growth y/y (stated)(%) | 19.0% | 19.0% | 21.0% | 21.0% | 21.0% | 21.0% | 21.0% | 24.0% | 27.0% | 56.0% | 19.0% | 20.0% | |
Commercial Solutions — Subscription Revenue($M)1 | 347 | 338 | 327 | 318 | 308 | 305 | 293 | 278 | 272 | 261 | 262 | 251 | |
Commercial Solutions subscription revenue growth y/y (stated)(%) | 13.0% | 11.0% | 11.0% | 14.0% | 13.0% | 17.0% | 12.0% | 11.0% | 12.0% | 9.0% | 8.0% | 5.0% | |
Subscription revenue share — North America (stated in MD&A)(%) | 60.0% | 60.0% | 60.0% | 59.0% | 61.0% | 59.0% | 59.0% | 59.0% | 58.0% | ||||
Subscription revenue share — Europe (stated in MD&A)(%) | 29.0% | 29.0% | 28.0% | 28.0% | 27.0% | 28.0% | 28.0% | 28.0% | 27.0% | ||||
Subscription revenue share — Asia Pacific & Other Locations (stated in MD&A)(%) | 11.0% | 11.0% | 12.0% | 13.0% | 12.0% | 13.0% | 13.0% | 13.0% | 15.0% | ||||
Total Professional Services and Other Revenues($M)6 | 161 | 153 | 128 | 129 | 130 | 124 | 112 | 118 | 115 | 116 | 109 | 122 | |
Total professional services revenue growth y/y (stated)(%) | 24.0% | 23.0% | 14.0% | 9.0% | 13.0% | 7.0% | 3.0% | -3.0% | -4.0% | 4.0% | 6.0% | 10.0% | |
R&D and Quality Solutions — Professional Services Revenue($M)1 | 101 | 95.2 | 80.6 | 81.3 | 82.2 | 77.7 | 66.7 | 72.5 | 69.8 | 67.6 | 63.2 | 73.7 | |
R&D and Quality services revenue growth y/y (stated)(%) | 23.0% | 23.0% | 21.0% | 12.0% | 18.0% | 15.0% | 6.0% | -2.0% | -3.0% | 1.0% | 7.0% | 13.0% | |
Commercial Solutions — Professional Services Revenue($M)1 | 59.7 | 57.6 | 47.6 | 47.5 | 47.7 | 46.6 | 45.6 | 45.9 | 45.1 | 48.8 | 45.9 | 47.9 | |
Commercial Solutions services revenue growth y/y (stated)(%) | 25.0% | 24.0% | 4.0% | 3.0% | 6.0% | -5.0% | -1.0% | -4.0% | -5.0% | 9.0% | 4.0% | 6.0% | |
Professional services revenue share — North America (stated in MD&A)(%) | 55.0% | 57.0% | 58.0% | 58.0% | 60.0% | 62.0% | 57.0% | 59.0% | 62.0% | ||||
Professional services revenue share — Europe (stated in MD&A)(%) | 39.0% | 37.0% | 36.0% | 36.0% | 34.0% | 31.0% | 36.0% | 35.0% | 31.0% | ||||
Professional services revenue share — Asia Pacific & Other Locations (stated in MD&A)(%) | 6.0% | 6.0% | 6.0% | 6.0% | 6.0% | 7.0% | 7.0% | 6.0% | 7.0% | ||||
Total Employee Headcount (period end)2 | 8,465 | 8,167 | 7,928 | 7,797 | 7,627 | 7,343 | 7,291 | 7,288 | 7,200 | 7,157 | 7,172 | 7,206 | |
Employee headcount growth y/y (stated)(%) | 11.0% | 11.0% | 9.0% | 7.0% | 6.0% | 3.0% | 2.0% | 1.0% | 1.0% | 4.0% | 6.0% | 11.0% | |
Net employee additions in period | 298 | 239 | 131 | 170 | 284 | 52 | 3 | 88 | 43 | -15 | -34 | 70 | |
Accrued Employee Compensation & Benefits — Current (period end)($M) | 42.2 | 52.6 | 45.9 | 41.5 | 40.7 | 39.1 | 39.4 | 34.6 | 37.2 | 38.8 | 43.4 | 38.4 | |
Non-GAAP Operating Income($M)3 | 416 | 395 | 367 | 365 | 353 | 350 | 308 | 304 | 280 | 261 | 239 | 235 | |
Non-GAAP operating income growth y/y (stated)(%) | 18.0% | 13.0% | 19.0% | 20.0% | 26.0% | 34.0% | 29.0% | 30.0% | 32.0% | 66.0% | 14.0% | 7.0% | |
Non-GAAP operating margin(%) | 44.8% | 44.8% | 43.8% | 45.0% | 44.7% | 46.1% | 42.7% | 43.5% | 41.4% | 40.1% | 37.9% | 38.1% | |
GAAP operating margin (stated)(%) | 29.6% | 30.9% | 29.4% | 29.7% | 24.8% | 30.8% | 26.1% | 25.9% | 24.6% | 23.9% | 21.4% | 20.8% | |
Non-GAAP Net Income($M)3 | 387 | 371 | 346 | 345 | 333 | 328 | 288 | 288 | 267 | 247 | 226 | 219 | |
Non-GAAP net income growth y/y (stated)(%) | 16.0% | 13.0% | 20.0% | 20.0% | 25.0% | 33.0% | 27.0% | 32.0% | 35.0% | 67.0% | 21.0% | 19.0% | |
Non-GAAP Diluted Net Income per Share | 2.35 | 2.24 | 2.06 | 2.04 | 1.99 | 1.97 | 1.74 | 1.75 | 1.62 | 1.50 | 1.38 | 1.34 | |
GAAP Diluted Net Income per Share (stated in release) | 1.66 | 1.57 | 1.45 | 1.40 | 1.19 | 1.37 | 1.18 | 1.13 | 1.04 | 0.98 | 0.90 | 0.83 | |
Non-GAAP Gross Profit($M)8 | 715 | 679 | 640 | 630 | 612 | 601 | 556 | 541 | 522 | 492 | 473 | 465 | |
Non-GAAP total gross margin(%) | 77.1% | 76.9% | 76.5% | 77.6% | 77.5% | 79.2% | 77.1% | 77.3% | 77.2% | 75.6% | 75.0% | 75.4% | |
GAAP total gross margin (stated)(%) | 75.0% | 75.0% | 74.5% | 75.4% | 75.3% | 77.1% | 74.9% | 75.1% | 74.8% | 73.3% | 72.4% | 72.8% | |
Non-GAAP subscription gross margin(%) | 86.6% | 86.8% | 86.7% | 86.6% | 86.2% | 88.1% | 86.7% | 86.2% | 86.5% | 85.9% | 85.7% | 85.5% | |
GAAP subscription gross margin (stated)(%) | 86.2% | 86.4% | 86.4% | 86.2% | 85.8% | 87.7% | 86.3% | 85.8% | 86.0% | 85.4% | 85.2% | 85.0% | |
Non-GAAP professional services gross margin(%) | 31.5% | 29.5% | 20.5% | 29.8% | 33.4% | 33.6% | 24.7% | 33.5% | 31.9% | 28.6% | 23.9% | 34.1% | |
GAAP professional services gross margin (stated)(%) | 21.6% | 20.3% | 8.8% | 18.2% | 21.9% | 23.2% | 13.2% | 22.5% | 20.3% | 17.7% | 11.5% | 23.3% | |
Non-GAAP cost of subscription revenues($M) | 102 | 96.7 | 94.5 | 91.3 | 90.8 | 75.6 | 80.7 | 79.9 | 76 | 75.5 | 74.6 | 71.7 | |
Non-GAAP cost of professional services and other revenues($M) | 110 | 108 | 102 | 90.4 | 86.5 | 82.6 | 84.6 | 78.7 | 78.3 | 83.1 | 83 | 80.2 | |
Non-GAAP Operating Expenses($M)3 | 299 | 283 | 273 | 265 | 259 | 251 | 248 | 237 | 242 | 231 | 234 | 230 | |
Non-GAAP research and development expense($M) | 160 | 157 | 148 | 139 | 139 | 136 | 134 | 124 | 127 | 121 | 121 | 116 | |
Non-GAAP sales and marketing expense($M) | 96.1 | 84.2 | 83 | 83.4 | 81.2 | 73.5 | 74.1 | 73.9 | 74.3 | 70.8 | 71.9 | 69.8 | |
Non-GAAP general and administrative expense($M) | 42.8 | 42.3 | 42.1 | 42.1 | 38.7 | 41.4 | 39.4 | 38.3 | 40.4 | 39.2 | 41.4 | 44.7 | |
Non-GAAP Operating Cash Flow (excluding excess tax benefit)($M)2 | 235 | 1,131 | 105 | 185 | 225 | 875 | 65.8 | 163 | 91.7 | 760 | 55.3 | 79.3 | |
Non-GAAP operating cash flow growth y/y (stated)(%) | 4.0% | 29.0% | 59.0% | 13.0% | 146.0% | 15.0% | 19.0% | 106.0% | -65.0% | 71.0% | |||
Excess tax (benefit) deficiency from stock-based compensation($M) | -3.30 | 4.10 | -2 | -7.70 | -13 | -2.60 | -3.80 | -0.90 | -1.10 | -3.10 | -2.50 | -3.30 | |
Next-Quarter Guidance — Total Revenue (high end, issued in period)($M)9 | 935 | 905 | 858 | 810 | 793 | 769 | 729 | 699 | 685 | 669 | 643 | 622 | |
Next-Quarter Guidance — Total Revenue (low end)($M) | 932 | 902 | 855 | 807 | 790 | 766 | 726 | 696 | 682 | 666 | 640 | 620 | |
Next-Quarter Guidance — Subscription Revenue($M) | 782 | 754 | 720 | 696 | 671 | 649 | 616 | 596 | 571 | 554 | 529 | 517 | |
Next-Quarter Guidance — Professional Services Revenue (high end)($M) | 153 | 151 | 138 | 114 | 122 | 120 | 113 | 103 | 114 | 115 | 114 | 105 | |
Next-Quarter Guidance — Professional Services Revenue (low end)($M) | 150 | 148 | 135 | 111 | 119 | 117 | 110 | 100 | 111 | 112 | 111 | 103 | |
Next-Quarter Guidance — Non-GAAP Operating Income (high end)($M) | 420 | 395 | 381 | 350 | 350 | 337 | 309 | 275 | 275 | 267 | 247 | 227 | |
Next-Quarter Guidance — Non-GAAP Operating Income (low end)($M) | 417 | 392 | 378 | 350 | 348 | 335 | 307 | 275 | 273 | 265 | 245 | 227 | |
Next-Quarter Guidance — Non-GAAP Diluted EPS (high end) | 2.34 | 2.22 | 2.14 | 1.92 | 1.95 | 1.90 | 1.75 | 1.57 | 1.58 | 1.54 | 1.43 | 1.30 | |
Next-Quarter Guidance — Non-GAAP Diluted EPS (low end) | 2.33 | 2.21 | 2.13 | 1.92 | 1.94 | 1.89 | 1.74 | 1.57 | 1.57 | 1.53 | 1.42 | 1.30 | |
Next-Quarter Guidance — Normalized Billings (legacy through Q3 FY2026)($M) | 1,450 | 527 | 663 | 678 | 1,184 | 449 | 605 | 630 | 1,040 | ||||
Full-Year Guidance — Total Revenue (high end, issued/updated in period)($M)13 | 3,687 | 3,645 | 3,600 | 3,169 | 3,140 | 3,100 | 3,055 | 2,725 | 2,710 | 2,710 | 2,740 | 2,355 | |
Full-Year Guidance — Total Revenue (low end)($M) | 3,682 | 3,635 | 3,585 | 3,166 | 3,134 | 3,090 | 3,040 | 2,722 | 2,704 | 2,700 | 2,725 | 2,353 | |
Full-Year Guidance — Total Subscription Revenue($M) | 3,080 | 3,060 | 3,040 | 2,672 | 2,657 | 2,625 | 2,585 | 2,272 | 2,257 | 2,245 | 2,250 | 1,897 | |
Full-Year Guidance — R&D and Quality Subscription Revenue($M) | 1,675 | 1,665 | 1,660 | 1,420 | 1,411 | 1,400 | 1,395 | 1,177 | 1,167 | 1,165 | 1,182 | 904 | |
Full-Year Guidance — Commercial Solutions Subscription Revenue($M) | 1,405 | 1,395 | 1,380 | 1,252 | 1,246 | 1,225 | 1,190 | 1,095 | 1,090 | 1,080 | 1,068 | 993 | |
Full-Year Guidance — Professional Services Revenue (high end)($M) | 607 | 585 | 560 | 497 | 483 | 475 | 470 | 453 | 453 | 465 | 490 | 458 | |
Full-Year Guidance — Professional Services Revenue (low end)($M) | 602 | 575 | 545 | 494 | 477 | 465 | 455 | 450 | 447 | 455 | 475 | 456 | |
Full-Year Guidance — Non-GAAP Operating Income (high end)($M) | 1,640 | 1,610 | 1,590 | 1,417 | 1,388 | 1,360 | 1,300 | 1,120 | 1,080 | 1,070 | 1,070 | 830 | |
Full-Year Guidance — Non-GAAP Operating Income (low end)($M) | 1,640 | 1,610 | 1,590 | 1,417 | 1,388 | 1,360 | 1,300 | 1,120 | 1,080 | 1,070 | 1,070 | 830 | |
Full-Year Guidance — Non-GAAP Diluted EPS (high end) | 9.21 | 9.05 | 8.85 | 7.93 | 7.78 | 7.63 | 7.32 | 6.44 | 6.22 | 6.16 | 6.16 | 4.76 | |
Full-Year Guidance — Non-GAAP Diluted EPS (low end) | 9.21 | 9.05 | 8.85 | 7.93 | 7.78 | 7.63 | 7.32 | 6.44 | 6.22 | 6.16 | 6.16 | 4.76 | |
Full-Year Guidance — Normalized Billings($M) | 3,870 | 3,825 | 3,780 | 3,369 | 3,355 | 3,320 | 3,265 | 2,900 | 2,880 | 2,865 | 2,900 | 2,576 | |
Full-Year Guidance — Expected customer term changes impact (Normalized vs. Calculated billings)($M) | -38 | -30 | -16 | 25 | 23 | -1 | 3 | -38 | |||||
Full-Year Guidance — Non-GAAP Operating Cash Flow($M) | 1,600 | 1,575 | 1,520 | 1,335 | 1,330 | 1,210 | 1,170 | 1,060 | 1,030 | 1,010 | 1,075 | 870 | |
Shares Repurchased — Open Market (Part II Item 2 / Note 11)3 | 1,408,414.00 | 1,255,029.00 | 801,735.00 | ||||||||||
Average Price Paid per Share Repurchased | 174.48 | 176.17 | 224.43 | ||||||||||
Share Repurchase Dollar Volume($M) | 246 | 221 | 180 | 0 | 0 | ||||||||
Remaining Share Repurchase Authorization (period end)($M) | 1,353 | 1,599 | 1,820 | ||||||||||
Total Stock-Based Compensation Expense($M)7 | 137 | 119 | 118 | 120 | 122 | 112 | 115 | 118 | 108 | 95.9 | 98.9 | 101 | |
Stock-based compensation — Research and development($M) | 62.2 | 51.6 | 50.8 | 52.8 | 53.4 | 48.0 | 47.2 | 48.0 | 49.0 | 41.7 | 43.0 | 45.7 | |
Stock-based compensation — Sales and marketing($M) | 27.9 | 24.6 | 25.1 | 24.5 | 25.4 | 22.3 | 22.3 | 21.2 | 23.7 | 23.0 | 23.8 | 23.5 | |
Stock-based compensation — General and administrative($M) | 28.5 | 27.2 | 25.5 | 26.3 | 26.4 | 27.5 | 31.4 | 34.0 | 20.9 | 17.0 | 17.2 | 17.5 | |
Stock-based compensation — Cost of professional services and other($M) | 15.9 | 14.2 | 15.0 | 14.8 | 14.8 | 12.8 | 12.7 | 12.9 | 13.2 | 12.5 | 13.4 | 12.9 | |
Stock-based compensation — Cost of subscription revenues($M) | 2.22 | 1.76 | 1.84 | 1.84 | 1.94 | 1.71 | 1.70 | 1.70 | 1.64 | 1.55 | 1.63 | 1.60 | |
Total unrecognized stock-based compensation cost (period end)($M) | 312 | 365 | 417 | 481 | 541 | 609 | 466 | 533 | 601 | 485 | 343 | 389 | |
Cash paid for employee tax withholdings on share-based compensation($M) | 27.8 | 38.5 | 22.0 | 25.1 | 26 | 20.2 | 19.6 | 17.3 | 17.9 | 24.6 | 21.0 | 20.8 | |
Unvested Restricted Stock Units — RSUs Outstanding (period end)5 | 3,771.90 | 4,089.50 | 890.10 | 1,137.10 | 1,371.80 | 1,615.70 | 880.00 | 1,130.20 | 1,369.20 | 1,583.80 | 1,011.70 | 1,300.70 | |
Unvested RSUs — Weighted-average grant-date fair value | 175.36 | 175.65 | 211.42 | 212.93 | 212.57 | 210.84 | 206.25 | 206.29 | 206.26 | 207.50 | 192.77 | 189.86 | |
RSUs granted in period | 95.20 | 3,867.30 | 27.60 | 20.80 | 33.00 | 983.70 | 18.50 | 25.80 | 62.30 | 882.70 | 25.80 | 26.70 | |
RSUs vested in period | 341.10 | 648.80 | 256.60 | 238.40 | 255.60 | 238.00 | 247.70 | 240.30 | 247.40 | 295.00 | 298.00 | 297.00 | |
RSUs forfeited in period | 71.80 | 19.10 | 18.00 | 17.10 | 21.30 | 10.10 | 20.80 | 24.40 | 29.40 | 15.60 | 16.80 | 32.70 | |
Unrecognized compensation cost for unvested RSUs (period end)($M) | 581 | 667 | 65 | 122 | 180 | 236 | 84 | 142 | 199 | 252 | 122 | 181 | |
Stock Options Outstanding (period end)8 | 14,922.40 | 15,120.70 | 15,134.90 | 15,272.20 | 15,638.80 | 16,442.40 | 14,633.90 | 15,008.30 | 15,284.80 | 12,751.50 | 11,147.80 | 11,333.70 | |
Stock options outstanding — Weighted-average exercise price | 181.57 | 181.78 | 181.99 | 182.00 | 181.98 | 182.36 | 177.65 | 177.29 | 177.48 | 165.33 | 157.20 | 157.07 | |
Stock options outstanding — Aggregate intrinsic value($M) | 521 | 291 | 523 | 1,669 | 1,600 | 888 | 860 | 619 | 500 | 551 | 626 | 527 | |
Stock options vested and exercisable (period end) | 9,464.20 | 9,444.50 | 6,558.30 | 6,598.90 | 6,862.40 | 7,484.40 | 6,331.00 | 6,332.50 | 6,358.70 | 6,180.10 | 4,962.40 | 4,805.50 | |
Stock options exercisable — Weighted-average exercise price | 159.94 | 159.56 | 136.89 | 137.04 | 138.67 | 143.18 | 130.97 | 132.76 | 135.60 | 136.47 | 123.63 | 124.41 | |
Stock options exercisable — Aggregate intrinsic value($M) | 503 | 291 | 496 | 1,019 | 1,000 | 712 | 676 | 526 | 426 | 441 | 449 | 375 | |
Stock options exercised in period | 86.50 | 19.40 | 76.80 | 312.70 | 741.80 | 242.70 | 271.10 | 174.40 | 48.80 | 178.80 | 107.10 | 149.00 | |
Stock options exercised — Aggregate intrinsic value($M) | 2 | 1 | 6 | 34 | 64 | 16 | 23 | 7 | 3 | 12 | 10 | 17 | |
Cash proceeds from stock option exercises($M) | 14.2 | 2.94 | 13.9 | 57.7 | 142 | 40.6 | 40.4 | 30.3 | 6.40 | 28.4 | 10.5 | 14.0 | |
Issued U.S. Patents (period end)1 | 137 | 123 | 111 | 105 | 98 | 91 | 83 | 82 | 79 | 74 | 74 | 70 | |
Issued International Patents (period end) | 11 | 11 | 11 | 11 | 11 | 11 | 13 | 13 | 13 | 13 | 13 | 13 | |
Short-Term Available-for-Sale Marketable Securities — Total Fair Value($M)12 | 5,431 | 5,416 | 5,140 | 4,977 | 4,473 | 4,103 | 4,031 | 4,019 | 3,719 | 3,568 | 3,324 | 3,199 | |
Short-term marketable securities — Total amortized cost($M) | 5,474 | 5,424 | 5,111 | 4,947 | 4,459 | 4,074 | 4,026 | 4,011 | 3,711 | 3,592 | 3,322 | 3,235 | |
Short-term investments — U.S. Treasury securities($M) | 1,661 | 1,585 | 1,338 | 1,265 | 1,064 | 870 | 887 | 790 | 742 | 635 | 715 | 764 | |
Short-term investments — Corporate notes and bonds($M) | 3,348 | 3,290 | 3,155 | 2,898 | 2,675 | 2,395 | 2,207 | 2,221 | 1,844 | 1,707 | 1,585 | 1,405 | |
Short-term investments — U.S. government agency securities($M) | 1.50 | 1.50 | 11.7 | 11.6 | 13.4 | 24.8 | 24.7 | 24.6 | 47.6 | 55.7 | 49.6 | 48.9 | |
Short-term investments — Asset-backed securities($M) | 134 | 206 | 262 | 332 | 402 | 469 | 530 | 588 | 645 | 656 | 607 | 571 | |
Short-term investments — Commercial paper($M) | 44.8 | 75.4 | 163 | 23.8 | 41 | 74.6 | 113 | 247 | 284 | 144 | 194 | ||
Short-term investments — Foreign government bonds($M) | 223 | 220 | 233 | 232 | 214 | 222 | 176 | 148 | 77.1 | 54.4 | 50.2 | 31.9 | |
Short-term investments — Certificates of deposit($M) | 27.7 | 27.7 | 27.7 | 20 | 20.1 | 20.1 | 64.1 | 64.1 | 44 | 98.6 | 94.3 | 112 | |
Short-term investments — Municipal securities($M) | 34.8 | 41.5 | 37.5 | 55.9 | 61.7 | 62.9 | 67.8 | 69.8 | 72.4 | 76.3 | 79.5 | 72.4 | |
Available-for-sale debt securities maturing within 1 year($M) | 1,011 | 1,152 | 1,026 | 1,159 | 930 | 889 | 1,067 | 1,122 | 1,177 | 1,165 | 920 | 1,113 | |
Available-for-sale debt securities maturing in 1 to 5 years($M) | 4,420 | 4,264 | 4,114 | 3,818 | 3,543 | 3,215 | 2,965 | 2,896 | 2,543 | 2,403 | 2,404 | 2,086 | |
Money market funds included in cash and cash equivalents($M) | 557 | 561 | 287 | 505 | 897 | 1,157 | 315 | 275 | 387 | 292 | 73.2 | 151 | |
Property and Equipment, Net — Total (period end)($M)4 | 79.5 | 73.5 | 70.3 | 66.1 | 61.2 | 58.5 | 55.9 | 55.7 | 56.7 | 58.0 | 58.5 | 57.6 | |
Property and equipment, net — North America($M) | 56.1 | 54.7 | 54.1 | 52.8 | 49.2 | 47.6 | 47.1 | 47.7 | 48.1 | 48.9 | 49.7 | 48.1 | |
Property and equipment, net — Europe($M) | 11.7 | 10.3 | 11.0 | 9.18 | 7.59 | 7.12 | 6.78 | 5.93 | 6.26 | 6.61 | 6.88 | 7.31 | |
Property and equipment, net — Asia Pacific($M) | 5.93 | 4.12 | 4.24 | 3.48 | 3.78 | 3.20 | 1.29 | 1.20 | 1.37 | 1.07 | 0.75 | 0.91 | |
Property and equipment, net — Other International($M) | 5.71 | 4.39 | 0.91 | 0.69 | 0.63 | 0.58 | 0.69 | 0.82 | 0.98 | 1.43 | 1.17 | 1.28 | |
Operating Lease Liabilities — Total (period end)($M)12 | 152 | 103 | 95.9 | 89.8 | 85.5 | 77.2 | 75.8 | 71.7 | 54.1 | 55.7 | 55.8 | 57.7 | |
Operating lease right-of-use (ROU) assets($M) | 129 | 82.1 | 75.6 | 73.8 | 71.5 | 63.7 | 63.9 | 60.3 | 43.2 | 44.6 | 45.6 | 48.1 | |
Operating lease cost recognized in period($M) | 6 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 4 | 4 | 4 | |
Operating cash outflows for operating leases($M) | 3.71 | 3.60 | -0.05 | 2.60 | 3.63 | 3.36 | 3.54 | 3.10 | 3.63 | 2.25 | 3.24 | 0.92 | |
ROU assets obtained in exchange for new operating lease liabilities($M) | 51.0 | 12.2 | 4.78 | 5.23 | 11.0 | 2.98 | 9.39 | 19.0 | 1.90 | 0.60 | -0.14 | 1.51 | |
Operating leases — Weighted-average discount rate(%) | 5.0% | 4.8% | 4.7% | 4.7% | 4.7% | 4.6% | 4.6% | 4.4% | 4.4% | 4.4% | 4.4% | 4.4% | |
Undiscounted future operating lease payments — Total($M) | 198 | 125 | 116 | 110 | 105 | 94.1 | 92.9 | 88.4 | 62.5 | 64.7 | 65.7 | 68.2 | |
Operating lease payments due — Remainder of fiscal year($M) | 7.58 | 11.3 | 0.45 | 2.09 | 6.05 | 2.96 | 6.33 | 9.55 | 1.67 | ||||
Operating lease payments due — Next fiscal year (Year 1)($M) | 13.8 | 19.4 | 14.9 | 14.3 | 15.4 | 14.4 | 8.82 | 7.69 | 11.5 | 11.0 | 10.2 | 11.3 | |
Operating lease payments due — Fiscal Year 2($M) | 22.3 | 15.8 | 18.5 | 17.5 | 17.2 | 15.1 | 13.5 | 12.4 | 10.5 | 10.0 | 10.7 | 10.6 | |
Operating lease payments due — Fiscal Year 3($M) | 21.7 | 15.2 | 15.0 | 13.6 | 13.4 | 11.4 | 14.1 | 12.7 | 9.37 | 9.18 | 9.80 | 9.72 | |
Operating lease payments due — Fiscal Year 4($M) | 19.6 | 13.1 | 14.1 | 12.7 | 12.3 | 10.5 | 10.7 | 9.63 | 6.65 | 6.63 | 9.12 | 9.08 | |
Operating lease liabilities — Less imputed interest($M) | 45.9 | 22.4 | 20.4 | 20.4 | 19.2 | 16.8 | 17.1 | 16.7 | 8.43 | 8.95 | 9.96 | 10.6 | |
Finite-Lived Intangible Assets, Net — Total (period end)($M)15 | 55.7 | 55.5 | 30.3 | 32.7 | 36.5 | 40.5 | 44.5 | 48.5 | 53.3 | 58.2 | 63.0 | 67.9 | |
Finite-lived intangible assets, gross — Total($M) | 209 | 205 | 163 | 163 | 163 | 163 | 163 | 177 | 177 | 177 | 177 | 177 | |
Finite-lived intangible assets — Accumulated amortization($M) | 154 | 150 | 133 | 130 | 127 | 123 | 119 | 129 | 124 | 119 | 114 | 109 | |
Intangible assets amortization expense($M) | 4 | 3 | 2 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 4 | 5 | |
Customer relationships intangible assets, net($M) | 37.1 | 38.2 | 29.6 | 31.6 | 34.3 | 37.1 | 39.9 | 42.8 | 45.7 | 48.6 | 51.4 | 54.3 | |
Customer relationships intangible assets, gross($M) | 126 | 124 | 113 | 113 | 113 | 113 | 113 | 113 | 113 | 113 | 113 | 113 | |
Developed/existing technology intangible assets, net($M) | 17.1 | 15.6 | 0.41 | 0.54 | 1.61 | 2.67 | 3.70 | 4.77 | 5.83 | 6.89 | 7.93 | 9 | |
Developed/existing technology intangible assets, gross($M) | 46.9 | 44.3 | 28.6 | 28.6 | 28.6 | 28.6 | 28.6 | 28.6 | 28.6 | 28.6 | 28.6 | 28.6 | |
Other intangible assets (databases & trade names), net($M) | 0.12 | 0.24 | 0.35 | 0.47 | 0.59 | 0.71 | 0.82 | 0.94 | 1.15 | 1.43 | 1.71 | 1.99 | |
Other intangible assets, gross($M) | 21.4 | 21.4 | 21.4 | 21.4 | 21.4 | 21.4 | 21.4 | 21.4 | 21.4 | 21.4 | 21.4 | 21.4 | |
Estimated future intangible amortization — Remainder of fiscal year($M) | 8.51 | 11.1 | 2.34 | 6.13 | 10.2 | 4.07 | 8.88 | 13.8 | 4.90 | ||||
Estimated future intangible amortization — Next fiscal year (Year 1)($M) | 14.8 | 13.3 | 8.92 | 8.92 | 8.92 | 8.92 | 14.2 | 14.2 | 14.2 | 14.2 | 18.6 | 18.6 | |
Estimated future intangible amortization — Fiscal Year 2($M) | 14.2 | 13.3 | 7.78 | 7.78 | 7.78 | 7.78 | 8.92 | 8.92 | 8.92 | 8.92 | 14.2 | 14.2 | |
Estimated future intangible amortization — Fiscal Year 3($M) | 10.6 | 10.3 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 8.92 | 8.92 | |
Estimated future intangible amortization — Fiscal Year 5 (legacy)($M) | 4.28 | 4.28 | 5.83 | 7.78 | |||||||||
Estimated future intangible amortization — Thereafter (legacy)($M) | 3.20 | 3.20 | 5.83 | ||||||||||
Income Before Income Taxes — Domestic U.S. (annual)1 | |||||||||||||
Effective Income Tax Rate(%) | 21.8% | 24.9% | 24.5% | 24.5% | 23.6% | 23.3% | 24.0% | 21.9% | 20.8% | ||||
U.S. Private Fixed Investment in Software (B985RC1Q027SBEA, SAAR, quarterly) | 809.30 | 790.80 | 774.90 | 762.80 | 744.70 | 723.00 | 705.30 | 694.50 | 680.30 | 663.90 | 650.50 | 637.80 | |
U.S. Personal Consumption Expenditures — Health Care (DHLCRC1Q027SBEA, SAAR, quarterly) | 3,790.30 | 3,699.90 | 3,667.00 | 3,614.90 | 3,529.80 | 3,464.70 | 3,417.80 | 3,358.20 | 3,288.20 | 3,244.40 | 3,159.40 | 3,079.00 | |
Total Revenues (GAAP)($M) | 928 | 883 | 836 | 811 | 789 | 759 | 721 | 699 | 676 | 650 | 631 | 617 | |
Total Cost of Revenues (GAAP)($M)2 | 232 | 221 | 214 | 200 | 195 | 174 | 181 | 174 | 170 | 174 | 174 | 168 | |
Cost of Subscription Revenues($M) | 106 | 99.1 | 96.5 | 94.2 | 93.8 | 78.3 | 83.5 | 82.6 | 78.8 | 78.1 | 77.4 | 74.4 | |
Cost of Professional Services and Other Revenues($M) | 126 | 122 | 117 | 105 | 101 | 95.5 | 97.5 | 91.8 | 91.6 | 95.7 | 96.5 | 93.2 | |
Gross Profit (GAAP)($M) | 696 | 662 | 623 | 612 | 594 | 585 | 540 | 525 | 506 | 477 | 457 | 449 | |
Total Operating Expenses (GAAP)($M)3 | 421 | 389 | 377 | 371 | 398 | 352 | 352 | 344 | 339 | 321 | 321 | 320 | |
Research and Development Expense($M) | 223 | 208 | 199 | 192 | 193 | 184 | 182 | 172 | 176 | 163 | 164 | 161 | |
Sales and Marketing Expense($M) | 127 | 111 | 110 | 111 | 109 | 98.6 | 99.2 | 98.7 | 102 | 97.3 | 99.2 | 96.8 | |
General and Administrative Expense($M) | 71.3 | 69.5 | 67.6 | 68.5 | 95.8 | 68.8 | 70.7 | 72.4 | 61.4 | 61.3 | 58.7 | 62.3 | |
Operating Income (GAAP)($M)4 | 275 | 273 | 246 | 241 | 196 | 234 | 188 | 181 | 167 | 155 | 135 | 129 | |
Other Income (Expense), Net($M) | 74.5 | 74.4 | 71.7 | 71.9 | 69.5 | 65.1 | 56.7 | 60.9 | 58.6 | 51.7 | 47.4 | 42.2 | |
Income Before Income Taxes($M) | 350 | 348 | 318 | 313 | 265 | 299 | 245 | 242 | 225 | 207 | 183 | 171 | |
Provision for Income Taxes($M) | 76.1 | 86.6 | 73.3 | 76.6 | 65.1 | 70.6 | 49.5 | 56.5 | 54 | 45.2 | 35.3 | 35.5 | |
GAAP Net Income($M) | 273 | 261 | 244 | 236 | 200 | 228 | 196 | 186 | 171 | 162 | 147 | 135 | |
GAAP Diluted Earnings per Share3 | 1.66 | 1.57 | 1.45 | 1.40 | 1.19 | 1.37 | 1.18 | 1.13 | 1.04 | 0.98 | 0.90 | 0.83 | |
GAAP Basic Earnings per Share | 1.68 | 1.60 | 1.44 | 1.23 | 1.40 | 1.15 | 1.06 | 1.00 | 0.84 | ||||
Weighted-Average Diluted Shares Outstanding | 165.10 | 166.00 | 168.90 | 167.70 | 166.20 | 165.00 | 164.60 | 164.40 | 163.80 | ||||
Weighted-Average Basic Shares Outstanding | 162.30 | 163.30 | 164.00 | 163.50 | 162.70 | 162.00 | 161.70 | 161.40 | 160.80 | ||||
Operating Cash Flow (GAAP)($M)6 | 239 | 1,127 | 107 | 193 | 238 | 877 | 69.5 | 164 | 92.9 | 764 | 57.8 | 82.6 | |
Other Depreciation and Amortization($M) | 10.9 | 11.6 | 8.30 | 9.70 | 10.1 | 9.80 | 9.90 | 9.90 | 11 | 8.50 | 8.60 | 8.40 | |
Cash Flow Change in Deferred Revenue($M) | -167 | -33 | 679 | -285 | -140 | -41.4 | 549 | -217 | -72.4 | -31.3 | 416 | -192 | |
Cash Flow Change in Accounts Receivable($M) | 71.7 | 697 | -946 | 108 | 70.3 | 523 | -761 | 109 | -2.80 | 490 | -597 | 123 | |
Cash Income Taxes Paid, Net($M) | 144 | 7.20 | 65.1 | 38.2 | 113 | 13.8 | 83.1 | 76.2 | 159 | 4.20 | 33.6 | 93.6 | |
Investing Cash Flow($M) | -63.5 | -389 | -168 | -495 | -389 | -52.1 | -15.7 | -298 | -114 | -272 | -86.7 | -73.3 | |
Financing Cash Flow($M) | -259 | -263 | -178 | 32.6 | 116 | 20.4 | 20.8 | 13 | -11.5 | 3.80 | -10.5 | -6.90 | |
Cash, Cash Equivalents and Short-Term Investments10 | |||||||||||||
Cash and Cash Equivalents($M) | 1,812 | 1,897 | 1,421 | 1,660 | 1,930 | 1,965 | 1,121 | 1,045 | 1,166 | 1,197 | 704 | 744 | |
Short-Term Investments($M) | 5,431 | 5,416 | 5,140 | 4,977 | 4,473 | 4,103 | 4,031 | 4,019 | 3,719 | 3,568 | 3,324 | 3,199 | |
Accounts Receivable, Net (Billed)($M) | 497 | 568 | 1,260 | 314 | 422 | 493 | 1,016 | 256 | 365 | 362 | 852 | 256 | |
Total Current Assets($M) | 7,946 | 8,063 | 7,998 | 7,112 | 6,995 | 6,708 | 6,309 | 5,447 | 5,368 | 5,245 | 5,003 | 4,336 | |
Goodwill($M) | 493 | 488 | 440 | 440 | 440 | 440 | 440 | 440 | 440 | 440 | 440 | 440 | |
Total Assets($M) | 9,060 | 9,130 | 8,979 | 8,097 | 7,999 | 7,765 | 7,340 | 6,453 | 6,331 | 6,188 | 5,911 | 5,226 | |
Total Current Liabilities($M) | 1,456 | 1,702 | 1,637 | 945 | 1,255 | 1,457 | 1,398 | 857 | 1,070 | 1,223 | 1,179 | 768 | |
Total Liabilities($M) | 1,629 | 1,825 | 1,765 | 1,057 | 1,361 | 1,554 | 1,507 | 951 | 1,146 | 1,298 | 1,266 | 846 | |
Retained Earnings($M) | 4,898 | 4,624 | 4,364 | 4,119 | 3,883 | 3,683 | 3,455 | 3,259 | 3,073 | 2,902 | 2,741 | 2,593 | |
Total Stockholders' Equity($M) | 7,431 | 7,304 | 7,215 | 7,041 | 6,639 | 6,211 | 5,832 | 5,501 | 5,185 | 4,889 | 4,645 | 4,380 | |
5 chỉ số không có số liệu trong 12 quý gần nhất — .
In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).
Phương pháp và các chỉ số bị loại
- Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
- Latest reported company quarter: Q2 FY2027 (ended July 31, 2026; Form 8-K filed August 27, 2026 and Form 10-Q filed September 3, 2026); latest completed fiscal year: FY2026 (ended January 31, 2026; Form 10-K filed March 25, 2026).
- Group 1 presents Normalized Billings ($776M in Q2 FY2027, +14% YoY; $3,514M in FY2026, +15% YoY), Calculated Billings ($751M in Q2 FY2027; $3,519M in FY2026), Customer Term Changes ($25M in Q2 FY2027), Unbilled Accounts Receivable split between subscription receivables ($45M) and professional services contract assets ($24M), and historical Subscription RPO (disclosed through Q3 FY2024 before standardization of termination-for-convenience clauses across Master Subscription Agreements).
- Group 2 presents annual customer counts from Form 10-K MD&A (1,552 total customers at FY2026: 1,196 R&D and Quality Solutions customers and 767 Commercial Solutions customers), multi-product customer cohort depth and average products per customer from Investor Day presentations (3.41 average R&D products and 4.08 average Commercial products per customer in FY2025), and historical Subscription Services Revenue Retention Rate (NRR %, 119%–127% across FY2017–FY2022).
- Group 3 unifies Commercial Solutions vs. R&D and Quality Solutions across both Subscription and Professional Services (which are split across four historical member tags in the database segment_values table), alongside stated YoY growth rates and MD&A geographic shares.
- Group 8 presents self-reported audited UK statutory filings from UK Companies House for Veeva Systems U.K. Limited (Company No. 07273355, FY2018–FY2025), providing UK/Europe/RoW revenue, subscription vs. professional services vs. intercompany revenue, and employee headcount across 6 departments.
- No parent-only financial statements exist under U.S. GAAP (Form 10-K Item 15 omits Schedule I), so no Consolidated − Parent subtraction is performed.
- All figures are strictly as reported (with verbatim quotes on hover for text-extracted metrics; bound figures such as 'more than 180 customers live on Vault CRM', 'more than 1,000 clinical trials on EDC', and 'more than 400 commercial customers' are excluded). The only arithmetic shown is period splitting (Q4 = full year − nine months; quarterly flow = YTD − prior YTD), displayed in italic with the formula.
Dữ liệu cập nhật 2026-11-03.
Mỗi KPI một trang riêng
Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số
Normalized Billings, Calculated Billings & Contract Visibility (Key)
- Normalized Billings ($M)22 kỳ
- Calculated Billings (Total Revenue + change in deferred revenue) ($M)27 kỳ
- Deferred Revenue — Current (period end) ($M)53 kỳ
- Unbilled Accounts Receivable — Total (period end) ($M)35 kỳ
- Subscription Remaining Performance Obligations — RPO (period end, legacy through Q3 FY2024) ($M)23 kỳ
- Capitalized Deferred Sales Commissions — Noncurrent (period end) ($M)35 kỳ
- Allowance for Credit Losses on Accounts Receivable (period end) ($M)51 kỳ
Customer Count, Multi-Product Cohort Adoption & Retention (Key)
Product Area Revenue Breakdown & Geographic Mix (Key)
Employee Headcount, Net Additions & Compensation (Key)
Financial Guidance & Non-GAAP Profitability Metrics
- Non-GAAP Operating Income ($M)39 kỳ
- Non-GAAP Net Income ($M)39 kỳ
- Non-GAAP Gross Profit ($M)39 kỳ
- Non-GAAP Operating Expenses ($M)39 kỳ
- Non-GAAP Operating Cash Flow (excluding excess tax benefit) ($M)22 kỳ
- Next-Quarter Guidance — Total Revenue (high end, issued in period) ($M)33 kỳ
- Full-Year Guidance — Total Revenue (high end, issued/updated in period) ($M)33 kỳ
Share Repurchases (Monthly & Quarterly) & Equity Compensation
Patents, Investment Portfolio, Facilities, Leases & Intangible Assets
- Issued U.S. Patents (period end)26 kỳ
- Short-Term Available-for-Sale Marketable Securities — Total Fair Value ($M)53 kỳ
- Property and Equipment, Net — Total (period end) ($M)54 kỳ
- Operating Lease Liabilities — Total (period end) ($M)30 kỳ
- Finite-Lived Intangible Assets, Net — Total (period end) ($M)52 kỳ
- Income Before Income Taxes — Domestic U.S. (annual) ($M)15 kỳ
Veeva Systems U.K. Limited — Subsidiary Self-Reported Statutory Filings
U.S. Life Sciences & Enterprise Software Industry Benchmarks (FRED)
- U.S. Producer Price Index (PPI) — Software Publishers (PCU511210511210, monthly)116 kỳ
- U.S. Producer Price Index (PPI) — Pharmaceutical Preparation Manufacturing (PCU325412325412, monthly)116 kỳ
- U.S. Consumer Price Index (CPI) — Medical Care Commodities (CUSR0000SAM1, monthly)115 kỳ
- U.S. Information Sector Employment (USINFO, thousands, monthly)116 kỳ
- U.S. Retail Sales — Pharmacies and Drug Stores (MRTSSM44611USS, monthly) ($M)115 kỳ
- U.S. Private Fixed Investment in Software (B985RC1Q027SBEA, SAAR, quarterly)38 kỳ
- U.S. Personal Consumption Expenditures — Health Care (DHLCRC1Q027SBEA, SAAR, quarterly)38 kỳ
Financial, Geographic & Product Context (from Database)
- Total Revenues (GAAP) ($M)58 kỳ
- Total Cost of Revenues (GAAP) ($M)58 kỳ
- Gross Profit (GAAP) ($M)58 kỳ
- Total Operating Expenses (GAAP) ($M)58 kỳ
- Operating Income (GAAP) ($M)58 kỳ
- GAAP Diluted Earnings per Share55 kỳ
- Operating Cash Flow (GAAP) ($M)56 kỳ
- Cash, Cash Equivalents and Short-Term Investments ($M)0 kỳ
Tài liệu nguồn mới nhất
Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Veeva Systems
- Veeva Systems Form 10-Q, filed 2026-08-27 ↗
- Veeva Systems SEC filing FY2027Q2.pdf ↗
- Veeva Systems 10-Q, filed 2026-08-27 (financial database) ↗
- Veeva Systems 10-K, filed 2026-03-20 (financial database) ↗
- Veeva Systems Form 10-K, filed 2026-03-20 ↗
- Veeva Systems Form 10-K, filed 2026-03-20 ↗
- Veeva Systems Earnings release (Form 8-K, Item 2.02), filed 2026-08-26 ↗
- Veeva Systems Earnings release (Form 8-K, Item 2.02), filed 2026-03-04 ↗
- UK Companies House — Veeva Systems U.K. Limited (Company No. 07273355) Full Statutory Accounts ↗
- Veeva Systems Form 10-Q, filed 2026-08-27 ↗
- Veeva Systems Form 10-Q, filed 2023-12-07 ↗
- Veeva Systems Form 10-K, filed 2023-03-30 ↗
See a number that looks wrong?